Kennedy Capital Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22M | Sell |
278,707
-181,585
| -39% | -$15.4M | 0.39% | 66 |
|
|
2026
Q1 | $39.7M | Sell |
460,292
-32,349
| -7% | -$2.9M | 0.84% | 5 |
|
|
2025
Q4 | $43M | Buy |
492,641
+1,692
| +0.3% | +$128K | 0.91% | 6 |
|
|
2025
Q3 | $28.1M | Buy |
490,949
+151,500
| +45% | +$8.72M | 0.62% | 18 |
|
|
2025
Q2 | $20M | Sell |
339,449
-18,170
| -5% | -$1.17M | 0.48% | 43 |
|
|
2025
Q1 | $26.2M | Sell |
357,619
-84,154
| -19% | -$6.95M | 0.63% | 16 |
|
|
2024
Q4 | $36.5M | Sell |
441,773
-9,960
| -2% | -$786K | 0.81% | 6 |
|
|
2024
Q3 | $32.3M | Sell |
451,733
-64,867
| -13% | -$4.58M | 0.71% | 8 |
|
|
2024
Q2 | $35.4M | Buy |
516,600
+64,127
| +14% | +$3.83M | 0.76% | 6 |
|
|
2024
Q1 | $24.3M | Buy |
452,473
+98,977
| +28% | +$5.32M | 0.5% | 23 |
|
|
2023
Q4 | $18.8M | Buy |
353,496
+43,870
| +14% | +$2.14M | 0.41% | 46 |
|
|
2023
Q3 | $15.4M | Buy |
309,626
+305,816
| +8,027% | +$17.1M | 0.37% | 59 |
|
|
2023
Q2 | $227K | Buy |
3,810
+40
| +1% | +$2.28K | 0.01% | 644 |
|
|
2023
Q1 | $214K | Buy |
3,770
+45
| +1% | +$2.88K | 0.01% | 602 |
|
|
2022
Q4 | $277K | Sell |
3,725
-634
| -15% | -$43.2K | 0.01% | 586 |
|
|
2022
Q3 | $260K | Hold |
4,359
| – | – | 0.01% | 584 |
|
|
2022
Q2 | $245K | Buy |
+4,359
| New | +$287K | 0.01% | 580 |
|
|
2021
Q2 | – | Sell |
-6,722
| Closed | -$415K | – | 642 |
|
|
2021
Q1 | $415K | Sell |
6,722
-3,112
| -32% | -$197K | 0.01% | 623 |
|
|
2020
Q4 | $641K | Sell |
9,834
-2,287
| -19% | -$131K | 0.01% | 573 |
|
|
2020
Q3 | $600K | Sell |
12,121
-24,751
| -67% | -$1.28M | 0.02% | 582 |
|
|
2020
Q2 | $1.76M | Buy |
36,872
+4,277
| +13% | +$206K | 0.05% | 516 |
|
|
2020
Q1 | $1.39M | Sell |
32,595
-16,454
| -34% | -$813K | 0.05% | 516 |
|
|
2019
Q4 | $2.89M | Sell |
49,049
-65,059
| -57% | -$3.53M | 0.07% | 480 |
|
|
2019
Q3 | $5.83M | Sell |
114,108
-52,366
| -31% | -$2.49M | 0.14% | 266 |
|
|
2019
Q2 | $7.04M | Sell |
166,474
-5,310
| -3% | -$231K | 0.17% | 224 |
|
|
2019
Q1 | $8.49M | Buy |
171,784
+5,840
| +4% | +$264K | 0.2% | 172 |
|
|
2018
Q4 | $7.18M | Buy |
165,944
+64,232
| +63% | +$3.2M | 0.18% | 208 |
|
|
2018
Q3 | $5.77M | Buy |
+101,712
| New | +$5.35M | 0.11% | 356 |
|
|
2016
Q3 | – | Sell |
-462,959
| Closed | -$11M | – | 727 |
|
|
2016
Q2 | $11M | Sell |
462,959
-9,686
| -2% | -$232K | 0.22% | 143 |
|
|
2016
Q1 | $11.2M | Buy |
472,645
+2,230
| +0.5% | +$54.5K | 0.23% | 122 |
|
|
2015
Q4 | $13.1M | Sell |
470,415
-3,311
| -0.7% | -$83.1K | 0.27% | 99 |
|
|
2015
Q3 | $9.79M | Buy |
473,726
+2,394
| +0.5% | +$60.6K | 0.2% | 158 |
|
|
2015
Q2 | $12.1M | Sell |
471,332
-11,402
| -2% | -$289K | 0.22% | 132 |
|
|
2015
Q1 | $12.2M | Sell |
482,734
-74,749
| -13% | -$1.82M | 0.21% | 145 |
|
|
2014
Q4 | $13.3M | Buy |
557,483
+34,578
| +7% | +$766K | 0.24% | 116 |
|
|
2014
Q3 | $10.3M | Buy |
522,905
+205,138
| +65% | +$4.22M | 0.2% | 169 |
|
|
2014
Q2 | $7.6M | Sell |
317,767
-4,768
| -1% | -$115K | 0.14% | 274 |
|
|
2014
Q1 | $8.58M | Sell |
322,535
-299,423
| -48% | -$7.12M | 0.16% | 242 |
|
|
2013
Q4 | $12.6M | Buy |
621,958
+16,919
| +3% | +$314K | 0.23% | 133 |
|
|
2013
Q3 | $10.6M | Buy |
605,039
+21,396
| +4% | +$370K | 0.2% | 165 |
|
|
2013
Q2 | $9.84M | Buy |
+583,643
| New | +$9.01M | 0.2% | 172 |
|
Other funds holding GMED
JT
SC
Kennedy Capital Management's GMED Position: Q2 2026 in Review
Kennedy Capital Management reduced its Globus Medical (GMED) stake by 39% in Q2 2026, selling an estimated $15.4M and leaving 278,707 shares worth $22M. The position accounts for 0.39% of the portfolio, ranked #66.
Kennedy Capital Management first reported a position in GMED in Q2 2013 and has held it in 41 quarters since. The position peaked at $43M in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Kennedy Capital Management held 278,707 shares of Globus Medical worth $22M as of Q2 2026.
- Kennedy Capital Management sold 181,585 Globus Medical shares in Q2 2026, an estimated $15.4M.
- Globus Medical made up 0.39% of Kennedy Capital Management's portfolio in Q2 2026, its #66 holding.
- Kennedy Capital Management first reported a position in Globus Medical in Q2 2013 and has held it in 41 quarters since.
- Kennedy Capital Management's Globus Medical position peaked at $43M in Q4 2025.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.